VCEL FY 2024 Earnings — Vericel Corporation Revenue & Financial Results | Market Cap Arena

VCELVericel Corporation

$2B

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$237M+20.1% YoY

Gross Profit

$172M72.6% margin

Operating Income

$5M1.9% margin

Net Income

$10M4.4% margin

EPS (Diluted)

$0.20

Cash Flow

Operating Cash Flow

$58M

Free Cash Flow

-$6M

Stock-Based Comp.

$36M

Balance Sheet

Total Assets

$433M

Total Liabilities

$141M

Stockholders' Equity

$292M

Cash & Equivalents

$75M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$237M	$198M	+20.1%
Gross Profit	$172M	$136M	+26.9%
Operating Income	$5M	-$6M	+169.9%
Net Income	$10M	-$3M	+425.6%